Theralase Technologies Inc. designs, develops, manufactures and markets patented, superpulsed laser technology utilized in biostimulation and biodestruction applications. The technology is safe and effective in the treatment of chronic pain, neural muscular-skeletal conditions and wound care. When combined with its patented, light-sensitive Photo Dynamic Compounds, Theralase laser technology is able to specifically target and destroy cancers, bacteria, viruses as well as microbial pathogens.
Wednesday, May 2, 2012
Why Invest in Theralase?
Proven clinical technology (TLC-1000)
Commercial therapeutic laser business and brand developed over last 17 years
Positive cash flow / double digit growth
PDC cancer destruction in animals helps pay for human trials